Antabio is a Labège, France-based biopharmaceutical company dedicated to the discovery of first-in-class small molecule compounds to treat severe infections caused by antibiotic-resistant bacterial pathogens. The company has a particular focus on life-threatening respiratory infections, including carbapenem-resistant nosocomial pneumonia and chronic pulmonary diseases. Antabio’s lead program, MEM-ANT3310, is being developed for the treatment of hospital-acquired infections such as nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii (CRAB) and carbapenem-resistant Enterobacterales (CRE).
Antabio is seeking a Clinical Project Manager to join our clinical R&D team and co-ordinate ongoing and future clinical trials.
The candidate must have excellent communication and management skills and be able to interact with a multidisciplinary team across different time zones.
Flexible with regards to work/home location (in France), with regular onsite (Toulouse) meetings required.